EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting

Press/Media

Period	2 Apr 2024

Media coverage

Title	EpicentRx to Present Positive Phase 2a Clinical Data with its AdAPT-001 TGF-β Trap Program in Checkpoint Inhibitor Resistant Patients at the 2024 AACR Meeting
Media name/outlet	BioSpace
Country/Territory	United States
Date	2/04/24
URL	https://www.biospace.com/article/releases/epicentrx-to-present-positive-phase-2a-clinical-data-with-its-adapt-001-tgf-%CE%B2-trap-program-in-checkpoint-inhibitor-resistant-patients-at-the-2024-aacr-meeting/?s=106
Persons	Christopher Larson